
<!DOCTYPE html>
<html id="htmlEl" lang="en">
<!-- NVCGInnerPageTemplate.aspx  -->
<head id="header"><meta http-equiv="X-UA-Compatible" content="IE=edge" /><meta charset="utf-8" /><meta name="viewport" content="width=device-width, user-scalable=yes, initial-scale=1, minimum-scale=1" /><title>
	CAR T Cells: Engineering Immune Cells to Treat Cancer - National Cancer Institute
</title><link rel="preconnect" crossorigin="" href="https://cdnjs.cloudflare.com" /><link rel="preconnect" crossorigin="" href="https://ajax.googleapis.com" /><link rel="preconnect" crossorigin="" href="https://fonts.gstatic.com" /><link rel="preconnect" href="https://static.cancer.gov" /><link id="gFonts" rel="stylesheet" href="https://fonts.googleapis.com/css?family=Noto+Sans:400,400i,700,700i" /><script src="//assets.adobedtm.com/f1bfa9f7170c81b1a9a9ecdcc6c5215ee0b03c84/satelliteLib-5b3dcf1f2676c378b518a1583ef5355acd83cd3d.js">

</script><link rel="apple-touch-icon" sizes="180x180" href="/publishedcontent/images/images/design-elements/icons/favicons/apple-touch-icon.png?v=oLa52veKe8" /><link rel="icon" type="image/png" href="/publishedcontent/images/images/design-elements/icons/favicons/favicon-32x32.png?v=oLa52veKe8" sizes="32x32" /><link rel="icon" type="image/png" href="/publishedcontent/images/images/design-elements/icons/favicons/favicon-16x16.png?v=oLa52veKe8" sizes="16x16" /><link rel="manifest" href="/publishedcontent/images/images/design-elements/icons/favicons/manifest.json?v=oLa52veKe8" /><link rel="mask-icon" href="/publishedcontent/images/images/design-elements/icons/favicons/safari-pinned-tab.svg?v=oLa52veKe8" color="#c0143c" /><link rel="shortcut icon" href="/publishedcontent/images/images/design-elements/icons/favicons/favicon.ico?v=oLa52veKe8" /><meta name="apple-mobile-web-app-title" content="Cancer.gov" /><meta name="application-name" content="Cancer.gov" /><meta name="msapplication-config" content="/publishedcontent/images/images/design-elements/icons/favicons/browserconfig.xml?v=oLa52veKe8" /><meta name="theme-color" content="#ffffff" /><script src="https://ajax.googleapis.com/ajax/libs/jquery/3.1.1/jquery.min.js" type="text/javascript"></script><script src="https://ajax.googleapis.com/ajax/libs/jqueryui/1.12.1/jquery-ui.min.js" defer="defer" type="text/javascript"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/jplayer/2.9.2/jplayer/jquery.jplayer.min.js" type="text/javascript"></script><script src="/PublishedContent/js/cdeConfig.__ve5dff1734974c62f53df79c43fb22ca4.js" type="text/javascript"></script><link href="/PublishedContent/Styles/Common.__v395115f63cc2bddc0d3aad563b082de7.css" rel="stylesheet" /><script src="/PublishedContent/js/Common.__v1d393e1363feae8840a09f8909bd72bd.js" defer="defer" type="text/javascript"></script><script src="/PublishedContent/js/InnerPage.__va70f1abec6d351842e19ce1a6fac6925.js" defer="defer" type="text/javascript"></script><link href="/PublishedContent/Styles/InnerPage.__vfcb9e8d73d608c858580d4cc6ea08c6a.css" rel="stylesheet" /><link rel="canonical" href="https://www.cancer.gov/about-cancer/treatment/research/car-t-cells" /><meta name="keywords" content="adoptive cell transfer, ACT, chimeric antigen receptors, CAR T cell, immunotherapy, cancer treatment, acute lymphoblastic leukemia, ALL, Renier Brentjens, Steven Rosenberg, Crystal Mackall, Stephan Grupp, Daniel Lee" /><meta name="description" content="Research on CAR T-cell therapy—a rapidly emerging form of cancer treatment, primarily for blood cancers like leukemia and lymphoma—is moving at a swift pace." /><meta name="content-language" content="en" /><meta name="dcterms.coverage" content="nciglobal,ncienterprise" /><meta name="dcterms.subject" content="About Cancer" /><meta name="dcterms.isPartOf" content="Treatment" /><meta name="dcterms.issued" content="12/06/2013" /><meta name="english-linking-policy" content="/policies/linking" /><meta name="espanol-linking-policy" content="/espanol/politicas/enlaces" /><meta name="dcterms.type" content="cgvArticle" /><meta property="og:title" content="CAR T Cells: Engineering Immune Cells to Treat Cancer" /><meta property="og:description" content="Research on CAR T-cell therapy—a rapidly emerging form of cancer treatment, primarily for blood cancers like leukemia and lymphoma—is moving at a swift pace." /><meta property="og:type" content="Website" /><meta property="og:site_name" content="National Cancer Institute" /><meta property="og:url" content="https://www.cancer.gov/about-cancer/treatment/research/car-t-cells" /><meta property="og:image" content="https://www.cancer.gov/PublishedContent/Images/images/research/science/cells/car-t-cell-receptor-social-media.__v50030840.jpg" /><meta name="twitter:card" content="summary" /><link rel="schema.dcterms" href="http://purl.org/dc/terms/" /><link href="https://www.cancer.gov/espanol/cancer/tratamiento/investigacion/celulas-t-y-car" hreflang="es" rel="alternate" /><link href="https://www.cancer.gov/about-cancer/treatment/research/car-t-cells" hreflang="en" rel="alternate" /></head>

<body id="Body1" class="cgvarticle" data-cde-contenttype="cgvarticle" data-cde-pagetemplate="NVCGInnerPageTemplate" data-cde-templatetheme="default" data-cde-contentid="675725">
<div class="skip"><a title="Skip to content" href="#main">Skip to content</a></div>
<div class="wa-data-element hide" data-prop3="/about-cancer/treatment/research/car-t-cells" data-prop6="CAR T Cells: Engineering Immune Cells to Treat Cancer" data-prop25="12/06/2013" data-prop44="Treatment" data-evar44="Treatment">

</div>
<!-- NOTIFICATION AREA -->


<!-- END NOTIFICATION AREA -->

<!-- HEADER -->
<header class="push" role="banner">
    <div id="nvcgSlSiteBanner" class="row">
	<div class="contentid-911584 slot-item only-SI nci-logo-pages large-12 columns">
		
<a href="/"><img src="/publishedcontent/images/images/design-elements/logos/nci-logo-full.__v1.svg" alt="National Cancer Institute" width="60%"></a>
	</div>
</div>
</header>
<!-- END HEADER -->
<!-- Begin Page -->
<div id="page">
    <!-- Global nav/utilit bar/language  -->
    <div class="fixedtotop">
        <div class="headroom-area">
            <!-- LANGUAGE BAR -->
            <div class="language-bar">
                <div class="row sitewide-language">
                    <div id="LangList1" class="large-12 columns">
	<ul>
		<li><a onclick="NCIAnalytics.ClickLink(this,&#39;Language Select Spanish&#39;);" href="/espanol/cancer/tratamiento/investigacion/celulas-t-y-car">Español</a></li>
	</ul>
</div>
                </div>
            </div><!-- end "language-bar" -->
            <!-- END LANGUAGE BAR -->

            <!-- UTILITY NAV -->
            <div id="nvcgSlUtilityBar" class="utility-background hide-for-medium-down">
	<div class="contentid-911757 slot-item only-SI row utility">
		<div class="rawHtml"><div class="large-12 columns utility">
<span><a href="/contact">1-800-4-CANCER</a></span>
<span><a href="https://livehelp.cancer.gov" onclick="window.open('https://livehelp.cancer.gov/', 'LiveHelp','scrollbars=yes,resizable=yes,menubar=yes,toolbar=yes,location=yes,width=650,height=600'); return false;">Live Chat</a></span>
<span><a href="/publications">Publications</a></span>
<span id="utility-dictionary" class="link"> <a href="/publications/dictionaries/cancer-terms">Dictionary</a></span>
</div></div>
	</div>
</div>
            <!-- END UTILITY NAV -->
        </div><!-- end "headroom-area" -->
        <!-- BEGIN NAVIGATION -->
        <!-- Begin nav-search bar -->
        <div class="nav-search-bar gradient header"><div id="nvcgSlMainNav" class="row">
	<div class="contentid-113330 slot-item first-SI">
		<div class="navigation">
			<div class="mobile-menu-bar"><button type="button" class="open-panel nav-header menu-btn">Menu</button><a href="/global/contact" class="nav-contact">Contact</a><a href="/publications/dictionaries/cancer-terms" class="nav-dictionary">Dictionary</a><button type="button" class="nav-search">Search</button></div><nav id="mega-nav" role="navigation">
				<ul class="menu nav-menu">
					<li class="nav-item lvl-1 contains-current has-children item-1"><div class="nav-item-title">
						<a href="/about-cancer">About Cancer</a>
					</div><ul class="mobile-item">
						<li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/about-cancer/causes-prevention">Cancer Causes and Prevention</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/causes-prevention/risk">Risk Factors </a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/causes-prevention/genetics">Genetics</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/causes-prevention/patient-prevention-overview-pdq">Cancer Prevention Overview</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/causes-prevention/research">Research</a>
							</div></li>
						</ul></li><li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/about-cancer/screening">Cancer Screening</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/screening/patient-screening-overview-pdq">Cancer Screening Overview</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/screening/screening-tests">Screening Tests</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/screening/research">Research</a>
							</div></li>
						</ul></li><li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/about-cancer/diagnosis-staging">Diagnosis and Staging</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/diagnosis-staging/symptoms">Symptoms </a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/diagnosis-staging/diagnosis">Diagnosis</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/diagnosis-staging/staging">Staging</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/diagnosis-staging/prognosis">Prognosis</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/diagnosis-staging/questions">Questions to Ask about Your Diagnosis</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/diagnosis-staging/research">Research</a>
							</div></li>
						</ul></li><li class="lvl-2 contains-current has-children"><div class="nav-item-title">
							<a href="/about-cancer/treatment">Cancer Treatment</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/treatment/types">Types of Cancer Treatment</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/treatment/side-effects">Side Effects of Cancer Treatment</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/treatment/clinical-trials">Clinical Trials Information</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/treatment/drugs">A to Z List of Cancer Drugs</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/treatment/cam">Complementary & Alternative Medicine (CAM)</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/treatment/questions">Questions to Ask about Your Treatment</a>
							</div></li><li class="lvl-3 current-page"><div class="nav-item-title">
								<a href="/about-cancer/treatment/research">Research</a>
							</div></li>
						</ul></li><li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/about-cancer/coping">Coping with Cancer</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/coping/feelings">Feelings and Cancer</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/coping/adjusting-to-cancer">Adjusting to Cancer</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/coping/self-image">Self-Image & Sexuality</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/coping/day-to-day">Day-to-Day Life</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/coping/caregiver-support">Support for Caregivers</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/coping/survivorship">Survivorship</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/coping/questions">Questions to Ask About Cancer</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/coping/research">Research</a>
							</div></li>
						</ul></li><li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/about-cancer/advanced-cancer">Advanced Cancer</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/advanced-cancer/care-choices">Choices for Care</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/advanced-cancer/talking">Talking about Your Advanced Cancer</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/advanced-cancer/feelings">Coping with Your Feelings During Advanced Cancer</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/advanced-cancer/planning">Planning for Advanced Cancer</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/advanced-cancer/caregivers">Advanced Cancer and Caregivers</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/advanced-cancer/questions">Questions to Ask about Advanced Cancer</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/advanced-cancer/research">Research</a>
							</div></li>
						</ul></li><li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/about-cancer/managing-care">Managing Cancer Care</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/managing-care/services">Finding Health Care Services</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/managing-care/track-care-costs">Costs & Medical Information</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/managing-care/advance-directives">Advance Directives</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/managing-care/using-trusted-resources">Using Trusted Resources</a>
							</div></li>
						</ul></li><li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/about-cancer/understanding">Understanding Cancer</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/understanding/what-is-cancer">What Is Cancer?</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/understanding/statistics">Cancer Statistics</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-cancer/understanding/disparities">Cancer Disparities</a>
							</div></li>
						</ul></li>
					</ul><div aria-expanded="false" aria-haspopup="true" class="sub-nav-mega">
						<div class="sub-nav-group-wrapper"><div class="sub-nav-group-subwrapper"><ul class="sub-nav-group"><li><a href="/about-cancer/understanding" class="sub-nav-group-header">Understanding Cancer</a><ul><li><a href="/about-cancer/understanding/what-is-cancer">What Is Cancer</a></li><li><a href="/about-cancer/understanding/statistics">Cancer Statistics</a></li><li><a href="/about-cancer/understanding/disparities">Cancer Disparities</a></li></ul></li></ul><ul class="sub-nav-group"><li><a href="/about-cancer/causes-prevention" class="sub-nav-group-header">Causes &amp; Prevention</a><ul><li><a href="/about-cancer/causes-prevention/risk">Risk Factors</a></li><li><a href="/about-cancer/causes-prevention/genetics">Genetics</a></li><li><a href="/about-cancer/causes-prevention/patient-prevention-overview-pdq">Cancer Prevention Overview</a></li></ul></li></ul><ul class="sub-nav-group"><li><a href="/about-cancer/screening" class="sub-nav-group-header">Screening</a><ul><li><a href="/about-cancer/screening/patient-screening-overview-pdq">Cancer Screening Overview</a></li><li><a href="/about-cancer/screening/screening-tests">Screening Tests</a></li></ul></li></ul><ul class="sub-nav-group"><li><a href="/about-cancer/diagnosis-staging" class="sub-nav-group-header">Diagnosis &amp; Staging</a><ul><li><a href="/about-cancer/diagnosis-staging/symptoms">Symptoms</a></li><li><a href="/about-cancer/diagnosis-staging/diagnosis">Diagnosis</a></li><li><a href="/about-cancer/diagnosis-staging/staging">Staging</a></li><li><a href="/about-cancer/diagnosis-staging/prognosis">Prognosis</a></li></ul></li></ul><ul class="sub-nav-group"><li><a href="/about-cancer/treatment" class="sub-nav-group-header">Treatment</a><ul><li><a href="/about-cancer/treatment/types">Types of Treatment</a></li><li><a href="/about-cancer/treatment/side-effects/">Side Effects</a></li><li><a href="/about-cancer/treatment/clinical-trials">Clinical Trials</a></li><li><a href="/about-cancer/treatment/drugs">Cancer Drugs</a></li><li><a href="/about-cancer/treatment/cam">Complementary &amp; Alternative Medicine</a></li></ul></li></ul><ul class="sub-nav-group"><li><a href="/about-cancer/coping" class="sub-nav-group-header">Coping</a><ul><li><a href="/about-cancer/coping/feelings">Feelings &amp; Cancer</a></li><li><a href="/about-cancer/coping/adjusting-to-cancer">Adjusting to Cancer</a></li><li><a href="/about-cancer/coping/self-image">Self Image &amp; Sexuality</a></li><li><a href="/about-cancer/coping/day-to-day">Day to Day Life</a></li><li><a href="/about-cancer/coping/survivorship">Survivorship</a></li><li><a href="/about-cancer/coping/caregiver-support">Support for Caregivers</a></li><li><a href="/about-cancer/coping/questions">Questions to Ask About Cancer</a></li></ul></li></ul><ul class="sub-nav-group"><li><a href="/about-cancer/advanced-cancer" class="sub-nav-group-header">Advanced Cancer</a><ul><li><a href="/about-cancer/advanced-cancer/care-choices">Choices For Care</a></li><li><a href="/about-cancer/advanced-cancer/talking">Talking About Advanced Cancer</a></li><li><a href="/about-cancer/advanced-cancer/feelings">Coping With Your Feelings</a></li><li><a href="/about-cancer/advanced-cancer/planning">Planning for Advanced Cancer</a></li><li><a href="/about-cancer/advanced-cancer/caregivers">Advanced Cancer &amp; Caregivers</a></li></ul></li></ul><ul class="sub-nav-group"><li><a href="/about-cancer/managing-care" class="sub-nav-group-header">Managing Cancer Care</a><ul><li><a href="/about-cancer/managing-care/services">Finding Health Care Services</a></li><li><a href="/about-cancer/managing-care/track-care-costs">Managing Costs and Medical Information</a></li><li><a href="/about-cancer/managing-care/advance-directives">Advance Directives</a></li><li><a href="/about-cancer/managing-care/using-trusted-resources">Using Trusted Resources</a></li></ul></li></ul></div></div>
					</div></li><li class="nav-item lvl-1 has-children item-2"><div class="nav-item-title">
						<a href="/types">Cancer Types</a>
					</div><ul class="mobile-item">
						<li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/types/aya">Adolescents and Young Adults with Cancer</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/types/aya/research">Reports, Research, and Literature</a>
							</div></li>
						</ul></li><li class="lvl-2"><div class="nav-item-title">
							<a href="/types/by-body-location">Cancers by Body Location/System</a>
						</div></li><li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/types/childhood-cancers">Childhood Cancers</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/types/childhood-cancers/late-effects-pdq">Late Effects of Childhood Cancer Treatment</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/types/childhood-cancers/pediatric-care-pdq">Pediatric Supportive Care</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/types/childhood-cancers/patient/unusual-cancers-childhood-pdq">Unusual Cancers of Childhood Treatment</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/types/childhood-cancers/pediatric-genomics-hp-pdq">Childhood Cancer Genomics</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/types/childhood-cancers/research">Study Findings</a>
							</div></li>
						</ul></li><li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/types/metastatic-cancer">Metastatic Cancer</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/types/metastatic-cancer/research">Metastatic Cancer Research</a>
							</div></li>
						</ul></li><li class="lvl-2"><div class="nav-item-title">
							<a href="/types/common-cancers">Common Cancer Types</a>
						</div></li><li class="lvl-2"><div class="nav-item-title">
							<a href="/types/recurrent-cancer">Recurrent Cancer</a>
						</div></li>
					</ul><div aria-expanded="false" aria-haspopup="true" class="sub-nav-mega">
						<div class="sub-nav-group-wrapper"><div class="sub-nav-group-subwrapper"><ul class="sub-nav-group cancer-types-border-container"><li><a href="/types/common-cancers" class="sub-nav-group-header">Common Cancer Types</a><ul><li><a href="/types/bladder">Bladder Cancer</a></li><li><a href="/types/breast">Breast Cancer</a></li><li><a href="/types/colorectal">Colorectal Cancer</a></li><li><a href="/types/kidney">Kidney (Renal Cell) Cancer</a></li><li><a href="/types/leukemia">Leukemia</a></li></ul><ul><li><a href="/types/liver">Liver Cancer</a></li><li><a href="/types/lung">Lung Cancer</a></li><li><a href="/types/lymphoma">Lymphoma</a></li><li><a href="/types/pancreatic">Pancreatic Cancer</a></li></ul><ul><li><a href="/types/prostate">Prostate Cancer</a></li><li><a href="/types/skin">Skin Cancer</a></li><li><a href="/types/thyroid">Thyroid Cancer</a></li><li><a href="/types/uterine">Uterine Cancer</a></li></ul></li></ul><ul class="sub-nav-group"><li><a href="/types" class="sub-nav-group-header">All Cancer Types</a><ul><li><a href="/types">A to Z List of Cancers</a></li><li><a href="/types/by-body-location">Cancers by Body Location</a></li><li><a href="/types/childhood-cancers">Childhood Cancers</a></li><li><a href="/types/aya">Adolescent &amp; Young Adult Cancers</a></li><li><a href="/types/metastatic-cancer">Metastatic Cancer</a></li><li><a href="/types/recurrent-cancer">Recurrent Cancer</a></li></ul></li></ul></div></div>
					</div></li><li class="nav-item lvl-1 has-children item-3"><div class="nav-item-title">
						<a href="/research">Research</a>
					</div><ul class="mobile-item">
						<li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/research/nci-role">NCI’s Role in Cancer Research</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/research/nci-role/intramural">Intramural Research</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/nci-role/extramural">Extramural Research</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/nci-role/bioinformatics">Bioinformatics, Big Data, and Cancer</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/nci-role/cancer-centers">NCI-Designated Cancer Centers</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/nci-role/fnlcr">Frederick National Laboratory for Cancer Research </a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/nci-role/partners-collaborators">Partners & Collaborators</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/nci-role/spotlight">Spotlight on Scientists</a>
							</div></li>
						</ul></li><li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/research/areas">Research Areas</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/research/areas/biology">Cancer Biology Research</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/areas/genomics">Cancer Genomics Research</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/areas/causes">Research on Causes of Cancer</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/areas/diagnosis">Cancer Diagnosis Research </a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/areas/prevention">Cancer Prevention Research </a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/areas/screening">Screening & Early Detection</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/areas/treatment">Cancer Treatment Research</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/areas/public-health">Cancer & Public Health</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/areas/disparities">Cancer Health Disparities</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/areas/childhood">Childhood Cancers</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/areas/clinical-trials">Clinical Trials</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/areas/global-health">Global Cancer Research</a>
							</div></li>
						</ul></li><li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/research/key-initiatives">Key Initiatives</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/research/key-initiatives/ras">The RAS Initiative</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/key-initiatives/moonshot-cancer-initiative">Cancer Moonshot℠</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/key-initiatives/immunotherapy">Immunotherapy</a>
							</div></li>
						</ul></li><li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/research/progress">Progress</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/research/progress/annual-report-nation">Annual Report to the Nation</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/progress/250-years-milestones">Milestones in Cancer Research and Discovery</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/progress/discovery">Stories of Discovery</a>
							</div></li>
						</ul></li><li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/research/resources">Resources for Researchers</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/research/resources/cryoem">Cryo-EM</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/research/resources/terminology">Terminology Resources</a>
							</div></li>
						</ul></li>
					</ul><div aria-expanded="false" aria-haspopup="true" class="sub-nav-mega">
						<div class="sub-nav-group-wrapper"><div class="sub-nav-group-subwrapper"><ul class="sub-nav-group"><li><a href="/research/nci-role" class="sub-nav-group-header">NCI's Role in Cancer Research</a><ul><li><a href="/research/nci-role/intramural">Intramural Research</a></li><li><a href="/research/nci-role/extramural">Extramural Research</a></li><li><a href="/research/nci-role/bioinformatics">Bioinformatics &amp; Big Data</a></li><li><a href="/research/nci-role/cancer-centers">NCI-Designated Cancer Centers</a></li><li><a href="/research/nci-role/fnlcr">Frederick National Lab</a></li><li><a href="/research/nci-role/partners-collaborators">Partners &amp; Collaborators</a></li><li><a href="/research/nci-role/spotlight">Spotlight on Scientists</a></li></ul></li></ul><ul class="sub-nav-group"><li><a href="/research/areas" class="sub-nav-group-header">NCI Research Areas</a><ul><li><a href="/research/areas/biology">Cancer Biology</a></li><li><a href="/research/areas/genomics">Cancer Genomics</a></li><li><a href="/research/areas/causes">Causes of Cancer</a></li><li><a href="/research/areas/diagnosis">Diagnosis</a></li><li><a href="/research/areas/prevention">Prevention</a></li><li><a href="/research/areas/screening">Screening &amp; Early Detection</a></li><li><a href="/research/areas/treatment">Treatment</a></li><li><a href="/research/areas/public-health">Cancer &amp; Public Health</a></li><li><a href="/research/areas/disparities">Cancer Health Disparities</a></li><li><a href="/research/areas/childhood">Childhood Cancer</a></li><li><a href="/research/areas/clinical-trials">Clinical Trials</a></li><li><a href="/research/areas/global-health">Global Health</a></li></ul></li></ul><ul class="sub-nav-group"><li><a href="/research/key-initiatives" class="sub-nav-group-header">Key Initiatives</a><ul><li><a href="/research/key-initiatives/moonshot-cancer-initiative">Cancer Moonshot</a></li><li><a href="/about-nci/organization/ccg/research/computational-genomics/gdc">Genomic Data Commons</a></li><li><a href="/research/areas/clinical-trials/nctn">National Clinical Trials Network</a></li><li><a href="/research/key-initiatives/ras">RAS Initiative</a></li></ul></li></ul><ul class="sub-nav-group"><li><a href="/research/progress" class="sub-nav-group-header">Progress</a><ul><li><a href="/research/progress/annual-report-nation">Annual Report to the Nation</a></li><li><a href="/research/progress/discovery">Stories of Discovery</a></li></ul></li><br /><br /><li><a href="/research/resources" class="sub-nav-group-header">Resources for Researchers</a></li></ul></div></div>
					</div></li><li class="nav-item lvl-1 has-children item-4"><div class="nav-item-title">
						<a href="/grants-training">Grants & Training</a>
					</div><ul class="mobile-item">
						<li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/grants-training/grants-funding">Research Grants</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/grants-funding/funding-opportunities">Research Funding Opportunities</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/grants-funding/contacts">Research Program Contacts</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/grants-funding/funding-strategy">Funding Strategy</a>
							</div></li>
						</ul></li><li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/grants-training/policies-process">Grants Policies and Process</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/policies-process/overview">Introduction to Grants Process</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/policies-process/nci-policies">NCI Grant Policies</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/policies-process/legal">Legal Requirements</a>
							</div></li>
						</ul></li><li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/grants-training/apply-grant">Apply for a Grant</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/apply-grant/development">Step 1: Application Development & Submission</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/apply-grant/receipt">Step 2: Application Receipt & Assignment</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/apply-grant/peer-review">Step 3: Peer Review and Funding Outcomes</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/apply-grant/award-issuance">Step 4: Award Negotiation & Issuance</a>
							</div></li>
						</ul></li><li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/grants-training/manage-award">Manage Your Award</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/manage-award/contacts">Grants Management Contacts</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/manage-award/monitoring">Monitoring</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/manage-award/prior-approvals">Prior Approvals</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/manage-award/report-audit">Annual Reporting and Auditing</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/manage-award/grant-transfer">Transfer of a Grant</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/manage-award/grant-closeout">Grant Closeout</a>
							</div></li>
						</ul></li><li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/grants-training/training">Training</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/training/at-nci">Cancer Training at NCI</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/training/resources-trainees">Resources for Trainees</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/training/funding">Funding for Cancer Training</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/training/idwb">Building a Diverse Workforce</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/training/about">About Center for Cancer Training (CCT)</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/grants-training/training/contact">CCT Staff & Contact</a>
							</div></li>
						</ul></li>
					</ul><div aria-expanded="false" aria-haspopup="true" class="sub-nav-mega">
						<div class="sub-nav-group-wrapper"><div class="sub-nav-group-subwrapper"><ul class="sub-nav-group"><li><a href="/grants-training/grants-funding" class="sub-nav-group-header">Research Grants</a><ul><li><a href="/grants-training/grants-funding/funding-opportunities">Funding Opportunities</a></li><li><a href="/grants-training/grants-funding/contacts">Research Program Contacts</a></li><li><a href="/grants-training/grants-funding/funding-strategy">Funding Strategy</a></li></ul></li><br /><li><a href="/grants-training/policies-process" class="sub-nav-group-header">Grants Policies &amp; Process</a><ul><li><a href="/grants-training/policies-process/overview">Introduction to Grants Process</a></li><li><a href="/grants-training/policies-process/legal">Legal Requirements</a></li><li><a href="/grants-training/policies-process/nci-policies">NCI Policies</a></li></ul></li></ul><ul class="sub-nav-group"><li><a href="/grants-training/apply-grant" class="sub-nav-group-header">Apply for a Grant</a><ul><li><a href="/grants-training/apply-grant/development">Application Development &amp; Submission</a></li><li><a href="/grants-training/apply-grant/receipt">Receipt &amp; Assignment</a></li><li><a href="/grants-training/apply-grant/peer-review">Peer Review &amp; Outcomes</a></li><li><a href="/grants-training/apply-grant/award-issuance">Award Issuance</a></li></ul></li></ul><ul class="sub-nav-group"><li><a href="/grants-training/manage-award" class="sub-nav-group-header">Manage Your Award</a><ul><li><a href="/grants-training/manage-award/contacts">Grants Management Contacts</a></li><li><a href="/grants-training/manage-award/monitoring">Monitoring</a></li><li><a href="/grants-training/manage-award/prior-approvals">Prior Approvals</a></li><li><a href="/grants-training/manage-award/report-audit">Annual Reporting &amp; Auditing</a></li><li><a href="/grants-training/manage-award/grant-transfer">Grant Transfer</a></li><li><a href="/grants-training/manage-award/grant-closeout">Grant Closeout</a></li></ul></li><br /><li><a href="/grants-training/contracts-business" class="sub-nav-group-header">Contracts &amp; Small Business</a></li></ul><ul class="sub-nav-group"><li><a href="/grants-training/training" class="sub-nav-group-header">Training</a><ul><li><a href="/grants-training/training/at-nci">Cancer Training at NCI (Intramural)</a></li><li><a href="/grants-training/training/resources-trainees">Resources for Trainees</a></li><li><a href="/grants-training/training/funding">Funding for Cancer Training (Extramural)</a></li><li><a href="/grants-training/training/diversity-training">Building a Diverse Workforce</a></li><li><a href="/grants-training/training/contact">Training Program Contacts</a></li></ul></li></ul></div></div>
					</div></li><li class="nav-item lvl-1 has-children item-5"><div class="nav-item-title">
						<a href="/news-events">News & Events</a>
					</div><ul class="mobile-item">
						<li class="lvl-2"><div class="nav-item-title">
							<a href="/news-events/press-releases/2019">Press Releases</a>
						</div></li><li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/news-events/media-resources">Resources for News Media</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/news-events/media-resources/contacts">Media Contacts</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/news-events/media-resources/multicultural">Multicultural Media Outreach Program</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/news-events/media-resources/reporting-fellowships">Cancer Reporting Fellowships</a>
							</div></li>
						</ul></li><li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/news-events/events">Events</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/news-events/events/scientific-meetings">Scientific Meetings & Lectures</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/news-events/events/conferences">Conferences</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/news-events/events/advisory-board-meetings">Advisory Board Meetings</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/news-events/events/social-media">Social Media Events</a>
							</div></li>
						</ul></li><li class="lvl-2"><div class="nav-item-title">
							<a href="/news-events/cancer-currents-blog">Cancer Currents Blog</a>
						</div></li>
					</ul><div aria-expanded="false" aria-haspopup="true" class="sub-nav-mega">
						<div class="sub-nav-group-wrapper"><div class="sub-nav-group-subwrapper"><ul class="sub-nav-group"><li><a href="/news-events/press-releases/2019" class="sub-nav-group-header">All Press Releases</a><ul><li><a href="/news-events/press-releases/2019">2019</a></li><li><a href="/news-events/press-releases/2018">2018</a></li><li><a href="/news-events/press-releases/2017">2017</a></li><li><a href="/news-events/press-releases/2016">2016</a></li><li><a href="/news-events/press-releases/2015">2015</a></li><li><a href="/news-events/press-releases/2014">2014</a></li></ul></li></ul><ul class="sub-nav-group"><li><a href="/news-events/media-resources" class="sub-nav-group-header">Media Resources</a><ul><li><a href="/news-events/media-resources/contacts">Media Contacts</a></li><li><a href="/news-events/media-resources/multicultural">Multicultural Media</a></li></ul></li></ul><ul class="sub-nav-group"><li><a href="/news-events/events" class="sub-nav-group-header">Events</a><ul><li><a href="/news-events/events/scientific-meetings">Scientific Meetings &amp; Lectures</a></li><li><a href="/news-events/events/conferences">Conferences</a></li><li><a href="/news-events/events/advisory-board-meetings">Advisory Board Meetings</a></li><li><a href="/news-events/events/social-media">Social Media</a></li></ul></li></ul><ul class="sub-nav-group"><li><a href="/news-events/cancer-currents-blog" class="sub-nav-group-header">Cancer Currents Blog</a></li></ul></div></div>
					</div></li><li class="nav-item lvl-1 has-children item-6"><div class="nav-item-title">
						<a href="/about-nci">About NCI</a>
					</div><ul class="mobile-item">
						<li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/about-nci/overview">NCI Overview</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/about-nci/overview/history">History</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-nci/overview/contributing">Contributing to Cancer Research</a>
							</div></li>
						</ul></li><li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/about-nci/leadership">Leadership</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/about-nci/leadership/director">Director's Page</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-nci/leadership/nci-deputy-director">Deputy Director's Page</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-nci/leadership/previous">Previous NCI Directors</a>
							</div></li>
						</ul></li><li class="lvl-2"><div class="nav-item-title">
							<a href="/about-nci/organization">NCI Organization</a>
						</div></li><li class="lvl-2"><div class="nav-item-title">
							<a href="/about-nci/advisory-boards">Advisory Boards and Review Groups</a>
						</div></li><li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/about-nci/budget">Budget & Appropriations</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/about-nci/budget/about-annual-plan">About the Annual Plan & Budget Proposal</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-nci/budget/congressional-justification">NCI Congressional Justification</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-nci/budget/fact-book">NCI Budget Fact Book</a>
							</div></li>
						</ul></li><li class="lvl-2"><div class="nav-item-title">
							<a href="/about-nci/careers">Careers at NCI</a>
						</div></li><li class="lvl-2"><div class="nav-item-title">
							<a href="/about-nci/visit">Visitor Information</a>
						</div></li><li class="lvl-2 has-children"><div class="nav-item-title">
							<a href="/about-nci/legislative">Legislative Activities</a>
						</div><ul class="mobile-item">
							<li class="lvl-3"><div class="nav-item-title">
								<a href="/about-nci/legislative/hearings">Hearings & Testimonies </a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-nci/legislative/current-congress">Current Congress </a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-nci/legislative/history">Legislative History</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-nci/legislative/committees">Committees of Interest</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-nci/legislative/resources">Legislative Resources</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-nci/legislative/recent-public-laws">Recent Public Laws</a>
							</div></li><li class="lvl-3"><div class="nav-item-title">
								<a href="/about-nci/legislative/contact">Contact</a>
							</div></li>
						</ul></li>
					</ul><div aria-expanded="false" aria-haspopup="true" class="sub-nav-mega">
						<div class="sub-nav-group-wrapper"><div class="sub-nav-group-subwrapper"><ul class="sub-nav-group"><li><a href="/about-nci/overview" class="sub-nav-group-header">Overview &amp; Mission</a><ul><li><a href="/about-nci/overview/history">History of NCI</a></li><li><a href="/about-nci/overview/contributing">Contributing to Cancer Research</a></li></ul></li></ul><ul class="sub-nav-group"><li><a href="/about-nci/leadership" class="sub-nav-group-header">Senior Leadership</a><ul><li><a href="/about-nci/leadership/director">Director</a></li><li><a href="/about-nci/leadership/nci-deputy-director">Deputy Director</a></li><li><a href="/about-nci/leadership/previous">Previous Directors</a></li></ul></li></ul><ul class="sub-nav-group"><li><a href="/about-nci/organization" class="sub-nav-group-header">NCI Organization</a><ul><li><a href="/about-nci/organization">Divisions, Offices &amp; Centers</a></li></ul></li></ul><ul class="sub-nav-group"><li><a href="/about-nci/advisory-boards" class="sub-nav-group-header">Advisory Boards &amp; Review Groups</a></li></ul><ul class="sub-nav-group"><li><a href="/about-nci/budget" class="sub-nav-group-header">Budget &amp; Appropriations</a><ul><li><a href="/about-nci/budget/">Current Year Budget</a></li><li><a href="/about-nci/budget/plan">Annual Plan &amp; Budget Proposal</a></li><li><a href="/about-nci/budget/congressional-justification">Congressional Justification</a></li><li><a href="/about-nci/budget/fact-book">NCI Budget Fact Book</a></li></ul></li></ul><ul class="sub-nav-group"><li><a href="/about-nci/legislative" class="sub-nav-group-header">Legislative Activities</a><ul><li><a href="/about-nci/legislative/hearings">Hearings &amp; Testimonies</a></li><li><a href="/about-nci/legislative/current-congress">Current Congress</a></li><li><a href="/about-nci/legislative/history">Legislative History</a></li><li><a href="/about-nci/legislative/committees">Committees of Interest</a></li><li><a href="/about-nci/legislative/resources">Legislative Resources</a></li><li><a href="/about-nci/legislative/recent-public-laws">Recent Public Laws</a></li></ul></li></ul><ul class="sub-nav-group"><li><a href="/about-nci/careers" class="sub-nav-group-header">Careers</a></li></ul><ul class="sub-nav-group"><li><a href="/about-nci/visit" class="sub-nav-group-header">Visitor Information</a></li></ul></div></div>
					</div></li>
				</ul>
			</nav>
		</div>
	</div><div class="contentid-911752 slot-item last-SI">
		<div class="rawHtml"><div class="search" role="search">
	<form action="/search/results" method="post" id="siteSearchForm" name="siteSearchForm" onsubmit="NCIAnalytics.SiteWideSearch(this);">
		<label class="hidden" for="swKeyword">Search</label>
		<input placeholder="search" class="searchString ui-autocomplete-input" id="swKeyword" maxlength="255" name="swKeyword" onblur="bSearchBoxBool=false;" onfocus="bSearchBoxBool=true;" value="" autocomplete="off" type="text" aria-autocomplete="list" aria-haspopup="true">
		<button class="searchSubmit" id="sitesearch" onclick="return siteSearchSubmit();" type="submit">
			<span class="hidden">Search</span>
		</button>
	</form>
</div>
</div>
	</div>
</div></div>
        <!-- End nav-search bar -->

        <!-- END NAVIGATION -->
    </div><!-- END Global nav/utility bar/language -->

		<!-- Begin MAIN CONTENT AREA -->
		<div class="main-content" id="content" tabindex="0">
            <div class="row general-page-body-container collapse">
                <div class="large-12 columns">
                    <div class="row">
                        <div id="cgvSlBreadcrumb" class="medium-8 columns bcrumbs">
	<div class="contentid-870117 slot-item only-SI">
		<ul class="breadcrumbs">
			<li><a href="/">Home</a></li><li><a href="/about-cancer">About Cancer</a></li><li><a href="/about-cancer/treatment">Cancer Treatment</a></li><li class="last-breadcrumb"><a href="/about-cancer/treatment/research">Research</a></li>
		</ul>
	</div>
</div>
                    </div> <!-- END "row" -->
                </div> <!-- END "large-12 columns" -->
                <div class="row">
                    <!--    SECTION NAVIGATION -->
                    <div id="nvcgSlSectionNav" class="medium-3 columns local-navigation">
	<div class="contentid-912171 slot-item only-SI">
		<div class="section-nav">
			<ul>
				<li class="level-0 has-children"><div>
					<a href="/about-cancer/treatment">Cancer Treatment</a>
				</div><ul>
					<li class="level-1 has-children"><div>
						<a href="/about-cancer/treatment/types">Types of Cancer Treatment</a>
					</div><ul style="display:none;">
						<li class="level-2"><div>
							<a href="/about-cancer/treatment/types/surgery">Surgery</a>
						</div></li><li class="level-2 has-children"><div>
							<a href="/about-cancer/treatment/types/radiation-therapy">Radiation Therapy </a>
						</div><ul style="display:none;">
							<li class="level-3"><div>
								<a href="/about-cancer/treatment/types/radiation-therapy/external-beam">External Beam Radiation</a>
							</div></li><li class="level-3"><div>
								<a href="/about-cancer/treatment/types/radiation-therapy/internal">Internal Radiation Therapy</a>
							</div></li><li class="level-3"><div>
								<a href="/about-cancer/treatment/types/radiation-therapy/side-effects">Side Effects</a>
							</div></li>
						</ul></li><li class="level-2"><div>
							<a href="/about-cancer/treatment/types/chemotherapy">Chemotherapy </a>
						</div></li><li class="level-2"><div>
							<a href="/about-cancer/treatment/types/immunotherapy">Immunotherapy</a>
						</div></li><li class="level-2"><div>
							<a href="/about-cancer/treatment/types/targeted-therapies">Targeted Therapy</a>
						</div></li><li class="level-2"><div>
							<a href="/about-cancer/treatment/types/hormone-therapy">Hormone Therapy </a>
						</div></li><li class="level-2"><div>
							<a href="/about-cancer/treatment/types/stem-cell-transplant">Stem Cell Transplant </a>
						</div></li><li class="level-2"><div>
							<a href="/about-cancer/treatment/types/precision-medicine">Precision Medicine</a>
						</div></li>
					</ul></li><li class="level-1"><div>
						<a href="/about-cancer/treatment/side-effects">Side Effects of Cancer Treatment</a>
					</div></li><li class="level-1 has-children"><div>
						<a href="/about-cancer/treatment/clinical-trials">Clinical Trials Information</a>
					</div><ul style="display:none;">
						<li class="level-2 has-children"><div>
							<a href="/about-cancer/treatment/clinical-trials/search">Find NCI-Supported Clinical Trials</a>
						</div><ul style="display:none;">
							<li class="level-3"><div>
								<a href="/about-cancer/treatment/clinical-trials/search/trial-guide">Steps to Find a Clinical Trial</a>
							</div></li><li class="level-3"><div>
								<a href="/about-cancer/treatment/clinical-trials/search/help">Help With Clinical Trials Search </a>
							</div></li>
						</ul></li><li class="level-2 has-children"><div>
							<a href="/about-cancer/treatment/clinical-trials/what-are-trials">What Are Clinical Trials? </a>
						</div><ul style="display:none;">
							<li class="level-3"><div>
								<a href="/about-cancer/treatment/clinical-trials/what-are-trials/where">Where Trials Take Place</a>
							</div></li><li class="level-3"><div>
								<a href="/about-cancer/treatment/clinical-trials/what-are-trials/types">Types of Clinical Trials</a>
							</div></li><li class="level-3"><div>
								<a href="/about-cancer/treatment/clinical-trials/what-are-trials/phases">Phases of Clinical Trials</a>
							</div></li><li class="level-3"><div>
								<a href="/about-cancer/treatment/clinical-trials/what-are-trials/randomization">Randomization</a>
							</div></li><li class="level-3"><div>
								<a href="/about-cancer/treatment/clinical-trials/what-are-trials/placebo">Use of Placebos</a>
							</div></li><li class="level-3"><div>
								<a href="/about-cancer/treatment/clinical-trials/what-are-trials/team">Research Team Members</a>
							</div></li>
						</ul></li><li class="level-2 has-children"><div>
							<a href="/about-cancer/treatment/clinical-trials/paying">Paying for Clinical Trials</a>
						</div><ul style="display:none;">
							<li class="level-3"><div>
								<a href="/about-cancer/treatment/clinical-trials/paying/insurance">Insurance Coverage and Clinical Trials</a>
							</div></li><li class="level-3"><div>
								<a href="/about-cancer/treatment/clinical-trials/paying/work-with-insurance">How to Work With Your Health Insurance Plan</a>
							</div></li><li class="level-3"><div>
								<a href="/about-cancer/treatment/clinical-trials/paying/federal-programs">Federal Government Programs</a>
							</div></li>
						</ul></li><li class="level-2 has-children"><div>
							<a href="/about-cancer/treatment/clinical-trials/patient-safety">Patient Safety</a>
						</div><ul style="display:none;">
							<li class="level-3"><div>
								<a href="/about-cancer/treatment/clinical-trials/patient-safety/informed-consent">Informed Consent</a>
							</div></li><li class="level-3"><div>
								<a href="/about-cancer/treatment/clinical-trials/patient-safety/childrens-assent">Children's Assent</a>
							</div></li><li class="level-3"><div>
								<a href="/about-cancer/treatment/clinical-trials/patient-safety/scientific-review">Scientific Review</a>
							</div></li><li class="level-3"><div>
								<a href="/about-cancer/treatment/clinical-trials/patient-safety/ending-trials-early">Ending Trials Early</a>
							</div></li>
						</ul></li><li class="level-2"><div>
							<a href="/about-cancer/treatment/clinical-trials/taking-part">Deciding to Take Part in a Trial</a>
						</div></li><li class="level-2"><div>
							<a href="/about-cancer/treatment/clinical-trials/questions">Questions to Ask about Treatment Clinical Trials</a>
						</div></li><li class="level-2"><div>
							<a href="/about-cancer/treatment/clinical-trials/nci-supported">Selected NCI-Supported Trials</a>
						</div></li>
					</ul></li><li class="level-1 has-children"><div>
						<a href="/about-cancer/treatment/drugs">A to Z List of Cancer Drugs</a>
					</div><ul style="display:none;">
						<li class="level-2"><div>
							<a href="/about-cancer/treatment/drugs/cancer-type">Drugs Approved for Different Types of Cancer</a>
						</div></li><li class="level-2"><div>
							<a href="/about-cancer/treatment/drugs/related-conditions">Drugs Approved for Conditions Related to Cancer</a>
						</div></li><li class="level-2"><div>
							<a href="/about-cancer/treatment/drugs/off-label">Off-Label Drug Use</a>
						</div></li><li class="level-2"><div>
							<a href="/about-cancer/treatment/drugs/access-experimental">Access to Experimental Drugs</a>
						</div></li>
					</ul></li><li class="level-1 has-children"><div>
						<a href="/about-cancer/treatment/cam">Complementary & Alternative Medicine (CAM)</a>
					</div><ul style="display:none;">
						<li class="level-2"><div>
							<a href="/about-cancer/treatment/cam/patient">CAM for Patients</a>
						</div></li><li class="level-2"><div>
							<a href="/about-cancer/treatment/cam/hp">CAM for Health Professionals</a>
						</div></li>
					</ul></li><li class="level-1"><div>
						<a href="/about-cancer/treatment/questions">Questions to Ask about Your Treatment</a>
					</div></li><li class="level-1 contains-current"><div>
						<a href="/about-cancer/treatment/research">Research</a>
					</div></li>
				</ul></li>
			</ul>
		</div>
	</div>
</div>
                    <!--    END SECTION NAVIGATION -->
                    <div class="medium-9 columns contentzone" id="main" tabindex="0" role="main">
                        <!-- ********************************* BEGIN Page Content ********************************** -->
                        <article>

                            <!-- PUBLIC ARCHIVE BANNER -->
                            <div id="cgvPublicArchiveBannerSl" class="row collapse">
	<div class="contentid-172410 slot-item only-SI large-12 columns">
		
	</div>
</div>
                            <!-- END PUBLIC ARCHIVE BANNER -->


                            <!-- BANNER SLOT -->
                            
                            <!-- END BANNER SLOT -->
                            
							<div class="resize-content">

							<!-- PAGE TITLE -->
							<h1><span>CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers</span></h1>
							
							<!-- END PAGE TITLE -->




                            <div class="page-options-container">
                                <!-- PAGE OPTIONS -->
                                <div id="PageOptionsControl1" class="page-options no-resize ">
                                    <ul>
                                            <li class="page-options--resize">
                                                <a title="Resize font" aria-label="Resize font" href="#"></a>
                                            </li>
                                            <li class="page-options--print">
                                                <a title="Print" aria-label="Print" href="#"></a>
                                            </li>
                                            <li class="page-options--email">
                                                <a title="Email" aria-label="Email" href="#"></a>
                                            </li>
                                            <li class="social-share social-share--facebook">
                                                <a title="Facebook" aria-label="Facebook" href="#"></a>
                                            </li>
                                            <li class="social-share social-share--twitter">
                                                <a title="Twitter" aria-label="Twitter" href="#"></a>
                                            </li>
                                            <li class="social-share social-share--pinterest">
                                                <a title="Pinterest" aria-label="Pinterest" href="#"></a>
                                            </li>
                                    </ul>
                                </div>
                                <!-- END PAGE OPTIONS -->
                            </div>


                            <div id="cgvBody">
	<div class="contentid-675725 slot-item only-SI">
				
          <figure class="image-right-medium centered-set">        <div class="centered-element">                      <img src="/PublishedContent/Images/images/research/science/cells/car-t-cell-receptor-article.__v50036827.jpg" alt=""><!--Comment--></img>
                                          	          <a href="/PublishedContent/Images/images/research/science/cells/car-t-cell-receptor-enlarge.__v50036827.jpg" target="_blank" class="article-image-enlarge no-resize">Enlarge</a>                                        </div>
                  <figcaption>
            <div class="caption-container no-resize">
                              
<p>Co-stimulatory signaling domains have been added to newer generations of CAR T cells to improve their ability to produce more T cells after infusion and survive longer in the circulation.</p>
                                            <div class="image-photo-credit">Credit: Brentjens R, et al. “Driving CAR T cells forward.” Nat Rev Clin Oncol. 2016 13, 370–383.</div>                          </div>
          </figcaption>
              </figure>
       	
<p>For years, the foundations of cancer treatment were surgery,<span>&nbsp;</span>chemotherapy, and<span>&nbsp;</span>radiation therapy. Over the last two decades, targeted therapies like<span>&nbsp;</span><a href="/about-cancer/treatment/drugs/imatinibmesylate" title="">imatinib<span>&nbsp;</span>(Gleevec&reg;)</a> and<span>&nbsp;</span><a href="/about-cancer/treatment/drugs/trastuzumab" title="">trastuzumab<span>&nbsp;</span>(Herceptin&reg;)</a>&mdash;drugs that target cancer cells by homing in on specific molecular changes seen primarily in those cells&mdash;have also cemented themselves as standard treatments for many cancers.</p>
<p>But over the past several years, <a href="/about-cancer/treatment/types/immunotherapy" title="">immunotherapy</a>&mdash;therapies that enlist and strengthen the power of a patient&rsquo;s immune system to attack tumors&mdash;has emerged as what many in the cancer community now call the &ldquo;fifth pillar&rdquo; of cancer treatment.</p>
<p>A rapidly emerging immunotherapy approach is called adoptive cell transfer (ACT): collecting and using patients&rsquo; own immune cells to treat their cancer. There are several types of ACT (see &ldquo;ACT: TILs, TCRs, and CARs&rdquo;), but, thus far,&nbsp;the one that has advanced the furthest in clinical development is called CAR T-cell therapy.</p>
<p>Until recently, the use of CAR T-cell therapy has been restricted to small clinical trials, largely in patients with advanced blood cancers. But these treatments have nevertheless captured the attention of researchers and the public alike because of the remarkable responses they have produced in some patients&mdash;both children and adults&mdash;for whom all other treatments had stopped working.</p>
<p>In 2017, two CAR T-cell therapies were approved by the Food and Drug Administration (FDA), one&nbsp;for the treatment of children with <a href="/types/leukemia/patient/child-all-treatment-pdq" title="">acute lymphoblastic leukemia</a> (ALL) and&nbsp;the other&nbsp;for adults with advanced lymphomas. Nevertheless, researchers caution that, in many respects, it&rsquo;s still early days for CAR T cells and other forms of ACT, including questions about whether they will ever be effective against solid tumors like breast and colorectal cancer.</p>
<p>The different forms of ACT &ldquo;are still being developed,&rdquo; said Steven Rosenberg, M.D., Ph.D., chief of the <a href="https://ccr.cancer.gov/Surgery-Branch">Surgery Branch</a> in NCI&rsquo;s Center for Cancer Research (CCR), an immunotherapy pioneer whose lab was the first <a href="https://www.ncbi.nlm.nih.gov/pubmed/20668228">to report successful cancer treatment with CAR T cells</a>.</p>
<p>But after several decades of painstaking research, the field has reached a tipping point, Dr. Rosenberg continued. In just the last few years, progress with CAR T cells and other ACT approaches has greatly accelerated, with researchers developing a better understanding of how these therapies work in patients and translating that knowledge into improvements in how they are developed and tested.</p>
<p>&ldquo;In the next few years,&rdquo; he said, &ldquo;I think we&rsquo;re going to see dramatic progress and push the boundaries of what many people thought was possible with these adoptive cell transfer&ndash;based treatments.&rdquo;</p>
<div class="accordion" data-otp-depth="2" data-otp-selector="">
<section id="living-drug">
<h2>A &ldquo;Living Drug&rdquo;</h2>
<p>CAR T cells are the equivalent of &ldquo;giving patients a living drug,&rdquo; explained Renier J. Brentjens, M.D., Ph.D., of Memorial Sloan Kettering Cancer Center in New York, another early leader in the CAR T-cell field.</p>
<p>As its name implies, the backbone of CAR T-cell therapy is <a class="definition" onclick="javascript:popWindow('defbyid','CDR0000044928&amp;version=Patient&amp;language=English'); return false;" href="/Common/PopUps/popDefinition.aspx?id=CDR0000044928&amp;version=Patient&amp;language=English">T cells</a>, which are often called the workhorses of the immune system because of their critical role in orchestrating the immune response and killing cells infected by pathogens. The therapy requires drawing blood from patients and separating out the T cells. Next, using a disarmed virus, the T cells are genetically engineered to produce receptors on their surface called chimeric antigen receptors, or CARs.</p>
<p>These receptors are &ldquo;synthetic molecules, they don&rsquo;t exist naturally,&rdquo; explained Carl June, M.D., of the University of Pennsylvania Abramson Cancer Center, during <a href="https://videocast.nih.gov/Summary.asp?file=19892&amp;bhcp=1">a recent presentation on CAR T cells</a> at the National Institutes of Health campus. Dr. June has led a series of CAR T cell clinical trials, largely in patients with leukemia.</p>
<p>These special receptors allow the T cells to recognize and attach to a specific protein, or <a class="definition" onclick="javascript:popWindow('defbyid','CDR0000046086&amp;version=Patient&amp;language=English'); return false;" href="/Common/PopUps/popDefinition.aspx?id=CDR0000046086&amp;version=Patient&amp;language=English">antigen</a>, on tumor cells. The CAR T cell therapies furthest along in development target an antigen found on B cells called CD19 (see &ldquo;The Making of a CAR T Cell&rdquo;).</p>
<p>Once the collected T cells have been engineered to express the antigen-specific CAR, they are &ldquo;expanded&rdquo; in the laboratory into the hundreds of millions.</p>
<p>The final step is the infusion of the CAR T cells into the patient (which is preceded by a &ldquo;lymphodepleting&rdquo; chemotherapy regimen). If all goes as planned, the engineered cells further multiply in the patient&rsquo;s body and, with guidance from their engineered receptor, recognize and kill cancer cells that harbor the antigen on their surfaces.</p>
<!--SIDEBAR 1-->
<div class="callout-box">
<p><strong>The Making of a CAR T Cell</strong></p>
<p>A growing number of CAR T-cell therapies are being developed and tested in clinical studies.</p>
<p>Although there are important differences between these therapies, they all share similar components. The CAR on the cell&rsquo;s surface is composed of fragments, or domains, of synthetic antibodies. The domains that are used can affect how well the receptor recognizes or binds to the antigen on the tumor cell.</p>
<p>The receptors rely on stimulation signals from inside the cell to do their job. So each CAR T cell has signaling and &ldquo;co-stimulatory&rdquo; domains inside the cell that signal the cell from the surface receptor. The different domains that are used can affect the cells&rsquo; overall function.</p>
<p>Over time, advances in the intracellular engineering of CAR T cells have improved the engineered T cells&rsquo; ability to produce more T cells after infusion into the patient (expansion) and survive longer in the circulation (persistence).</p>
<p>Advances have also been made in how long it takes to produce a batch of CAR T cells. Although it initially took several weeks, many labs have now reduced the time to less than 7 days.</p>
</div>
</section>
<section id="option">
<h2>A Possible Option Where None Had Existed</h2>
<p>The initial development of CAR T-cell therapies has focused largely on ALL, the most common cancer in children.</p>
<p>More than 80% of children diagnosed with ALL that arises in B cells&mdash;the predominant type of pediatric ALL&mdash;will be cured by intensive chemotherapy. But for patients whose cancers return after chemotherapy or a stem cell transplant, the treatment options are &ldquo;close to none,&rdquo; said Stephan Grupp, M.D., Ph.D., of the Children&rsquo;s Hospital of Philadelphia (CHOP).</p>
<p>Relapsed ALL, in fact, is a leading cause of death from childhood cancer.</p>
<p>Dr. Grupp has led several trials of CAR T cells in children and young adults with ALL that had recurred or was not responding to existing therapies. In <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267531/">one of these</a> earlier trials, which used CD19-targeted CAR T cells, all signs of cancer disappeared (a complete response) in 27 of the 30 patients treated in the study, with many of these patients continuing to show no signs of recurrence long after the treatment.</p>
<p>These early successes laid the foundation for a <a href="https://ash.confex.com/ash/2016/webprogram/Paper90831.html">larger trial</a> of a CD19-targeted CAR T-cell therapy, called <a href="/about-cancer/treatment/drugs/tisagenlecleucel" title="">tisagenlecleucel (Kymriah&trade;)</a>, for children and adolescents with ALL. Many of the patients who participated in the trial, funded by Novartis, had complete and long-lasting remissions. Based on the trial results, <a href="/news-events/cancer-currents-blog/2017/tisagenlecleucel-fda-childhood-leukemia" title="">FDA approved tisagenlecleucel in August 2017</a>.</p>
<p>Similar <a href="https://www.ncbi.nlm.nih.gov/pubmed/25319501">results have been seen</a> in trials of CD19-targeted CAR T cells led by researchers in CCR&rsquo;s <a href="https://ccr.cancer.gov/Pediatric-Oncology-Branch">Pediatric Oncology Branch</a> (POB).</p>
<p>The progress made with CAR T-cell therapy in children with ALL &ldquo;has been fantastic,&rdquo; said Terry Fry, M.D., a lead investigator on several POB trials of CAR T cells. CD19-targeted CAR T cells were initially tested in adults. But the fact that the first approval is for a therapy for children and adolescents with ALL is a watershed moment, Dr. Fry continued.</p>
<p>The agency approving a new therapy in children before adults &ldquo;is almost unheard of in cancer,&rdquo; he said.</p>
<p>However, there is no shortage of promising data on CAR T cells used to treat adult patients with blood cancers. CD19-targeted CAR T cells have produced strong results not only in patients with ALL but also in patients with lymphomas. For example, in <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322257/">a small NCI-led trial</a> of CAR T cells primarily in patients with advanced diffuse large B-cell lymphoma, more than half had complete responses to the treatment.</p>
<p>&ldquo;Our data provide the first true glimpse of the potential of this approach in patients with aggressive lymphomas, who, until this point, were virtually untreatable,&rdquo; said the trial&rsquo;s lead investigator, James Kochenderfer, M.D., of the NCI <a href="https://ccr.cancer.gov/Experimental-Transplantation-and-Immunology-Branch">Experimental Transplantation and Immunology Branch</a>.</p>
<p>Since that time, <a href="https://www.ncbi.nlm.nih.gov/pubmed/29226797">findings from a larger trial</a> funded by Kite Pharmaceuticals (which has a research agreement with NCI to develop ACT-based therapies) have confirmed these earlier results and formed the basis for <a href="/news-events/cancer-currents-blog/2017/yescarta-fda-lymphoma" title="">FDA's approval of Kite&rsquo;s CAR T-cell product, axicabtagene ciloleucel (Yescarta&trade;)</a>,&nbsp;for some patients with lymphoma.</p>
<p>The results in lymphoma to date &ldquo;have been incredibly successful,&rdquo; Dr. Kochenderfer said, &ldquo;and CAR T cells are almost certain to become a frequently-used therapy for several types of lymphoma.&rdquo;</p>
<p>The rapid advances in and growth of CAR T-cell therapy has exceeded the expectations of even those who were early believers in its potential.</p>
<p>&ldquo;Did I think it could work? Yes,&rdquo; Dr. Brentjens said. But he initially thought it would be a &ldquo;boutique therapy&rdquo; limited to a very small, defined patient group. The experience over the past 5 years, including the entry of the biopharmaceutical industry into the field, has altered his outlook.</p>
<p>&ldquo;We have cohorts of patients who would have been considered terminal who are now in durable and meaningful remissions with good quality of life for up to 5 years,&rdquo; he continued. &ldquo;So the enthusiasm for this technology is now quite high.&rdquo;</p>
</section>
<section id="side-effects">
<h2>Understanding, Managing Side Effects</h2>
<p>Like all cancer therapies, CAR T-cell therapy can cause several worrisome, and sometimes fatal, side effects. One of the most frequent is <a class="definition" onclick="javascript:popWindow('defbyid','CDR0000791353&amp;version=Patient&amp;language=English'); return false;" href="/Common/PopUps/popDefinition.aspx?id=CDR0000791353&amp;version=Patient&amp;language=English">cytokine release syndrome</a> (CRS).</p>
<p>As part of their immune-related duties, T cells release cytokines, chemical messengers that help to stimulate and direct the immune response. In the case of CRS, there is a rapid and massive release of cytokines into the bloodstream, which can lead to dangerously high fevers and precipitous drops in blood pressure.</p>
<p>Ironically, CRS is considered an &ldquo;on-target&rdquo; effect of CAR T-cell therapy&mdash;that is, its presence demonstrates that active T cells are at work in the body. Generally, patients with the most extensive disease prior to receiving CAR T cells are more likely to experience severe CRS, Dr. Kochenderfer explained.</p>
<p>In many patients, both children and adults, CRS can be managed with standard supportive therapies, including steroids. And as researchers have gained more experience with CAR T-cell therapy, they&rsquo;ve learned how to better manage the more serious cases of CRS.</p>
<p>Several years ago, for instance, the research team at CHOP noticed that patients experiencing severe CRS all had particularly high levels of IL-6, a <a class="definition" onclick="javascript:popWindow('defbyid','CDR0000046130&amp;version=Patient&amp;language=English'); return false;" href="/Common/PopUps/popDefinition.aspx?id=CDR0000046130&amp;version=Patient&amp;language=English">cytokine</a> that is secreted by T cells and <a class="definition" onclick="javascript:popWindow('defbyid','CDR0000044054&amp;version=Patient&amp;language=English'); return false;" href="/Common/PopUps/popDefinition.aspx?id=CDR0000044054&amp;version=Patient&amp;language=English">macrophages</a> in response to inflammation. So they turned to therapies that are approved to treat inflammatory conditions like juvenile arthritis, including the drug tocilizumab (Actemra&reg;), which blocks IL-6 activity.</p>
<p>The approach worked, rapidly resolving the problem in most patients. Since that time, tocilizumab has become a standard therapy for managing severe CRS.</p>
<p>&ldquo;We&rsquo;ve learned how to grade [CRS], we&rsquo;ve learned how to treat it,&rdquo; Dr. Grupp said during an FDA advisory committee meeting on Novartis&rsquo; CD19-targeted therapy. &ldquo;And IL-6 blockade was really the key.&rdquo;</p>
<p>Another potential side effect of CAR T-cell therapy&mdash;an off-target effect&mdash;is a mass die off of B cells, known as B-cell aplasia. CD19 is also expressed on normal B cells, which are responsible for producing <a class="definition" onclick="javascript:popWindow('defbyid','CDR0000044918&amp;version=Patient&amp;language=English'); return false;" href="/Common/PopUps/popDefinition.aspx?id=CDR0000044918&amp;version=Patient&amp;language=English">antibodies</a> that kill pathogens. These normal B cells are also often killed by the infused CAR T cells. To compensate, many patients must receive immunoglobulin therapy, which provides them with the necessary antibodies to fight off infections.</p>
<p>More recently, another serious and potentially fatal side effect&mdash;swelling in the brain, or cerebral edema&mdash;has been seen in some of the larger trials being conducted to support potential FDA approval of CAR T-cell therapies for patients with advanced leukemias. One company, in fact, decided to halt further development of their leading CAR T-cell therapy after several patients in clinical trials died as a result of treatment-induced cerebral edema.</p>
<p>However, the problem appears to be limited, with the leaders of other trials of CAR T-cell therapies reporting no instances of cerebral edema.</p>
<p>Other so-called neurotoxicities&mdash;such as confusion or seizure-like activity&mdash;have been seen in most CAR T-cell therapy&nbsp;trials. But in nearly all patients the problem is short lived and reversible, Dr. Brentjens said.</p>
<p>There was speculation early on that these neurotoxicities might be related to CRS. But although researchers are still trying to get their hands around the mechanisms, he added, &ldquo;I think most investigators [in the field] would agree that they&rsquo;re distinct from CRS.&rdquo;</p>

          <figure class="image-center-full centered-set">        <div class="centered-element">                      <img src="/PublishedContent/Images/images/research/science/cells/car-t-tcr-t-cells-article.__v50025354.jpg" alt=""><!--Comment--></img>
                                                </div>
                  <figcaption>
            <div class="caption-container no-resize">
                              
<p>CAR T cells and TCR T cells are engineered to produce special receptors on their surfaces. They are then expanded in the laboratory and returned to the patient.</p>
                                            <div class="image-photo-credit">Credit: National Cancer Institute</div>                          </div>
          </figcaption>
              </figure>
       
<p></p>
</section>
<section id="new-target">
<h2>New Target Antigens for CAR T Cells</h2>
<p>Research on CAR T cells is continuing at a swift pace, mostly in patients with blood cancers, but also in patients with solid tumors. As the biopharmaceutical industry has become more involved in the field, for instance, the number of clinical trials testing CAR T cells has expanded dramatically, from just a handful 5 years ago to more than 180 and counting.</p>
<p>Most of the trials conducted to date have used CD19-targeted CAR T cells. But that&rsquo;s changing quickly, in part out of necessity.</p>
<p>Some patients with ALL, for example, don&rsquo;t respond to the CD19-targeted therapy. And even in those who experience a complete response, up to a third will see their disease return within a year, Dr. Fry said. Many of these disease recurrences have been linked to ALL cells&rsquo; no longer expressing CD19, a phenomenon known as antigen loss.</p>
<p>So, in children and young adults with advanced ALL, researchers in NCI&rsquo;s POB are testing CAR T cells that target the CD22 protein, which is also often overexpressed by ALL cells. In the <a href="https://www.ncbi.nlm.nih.gov/pubmed/29155426">first trial of CD22-targeted CAR T cells</a>, most treated patients had complete remissions, including patients whose cancer had progressed after initially having a complete response to CD19-targeted therapy.</p>
<p>Similar to the case with the CD19-targeted CAR T cells, however, relapses after CD22-targeted treatment are not uncommon, Dr. Fry explained.</p>
<p>&ldquo;There is definitely room to improve from the standpoint of the durability of remissions,&rdquo; he said.</p>
<p>One potential way to improve durability and perhaps at least forestall antigen loss, if not prevent it altogether, is to attack multiple antigens simultaneously. Several research groups, for example, are testing T cells that target both CD19 and&nbsp;CD22 in early-phase clinical trials.</p>
<p>CHOP researchers are also testing a CAR T cell that targets both CD19 and CD123, another antigen commonly found on leukemia cells. <a href="https://www.ncbi.nlm.nih.gov/pubmed/27571406">Early studies in animal models</a> have suggested that this dual targeting may prevent antigen loss.</p>
<p>Antigen targets for CAR T-cell therapy have been identified in other blood cancers as well, including multiple myeloma.</p>
<p>Dr. Kochenderfer and his colleagues at NCI, as part of the collaboration with Kite, have developed CAR T cells that target the BCMA protein, which is found on nearly all myeloma cells.&nbsp;</p>
<p>In an&nbsp;early-phase&nbsp;<a href="/news-events/cancer-currents-blog/2017/car-t-cell-multiple-myeloma" title="">clinical trial of BCMA-targeted CAR T cells</a> in patients with advanced multiple myeloma, more than half of the patients had a&nbsp;complete response to the treatment. Kite has now launched a trial to test the BCMA-targeted T cells in a larger group of patients.</p>
</section>
<section id="expanding">
<h2>Expanding CAR T Cells to Solid Tumors?</h2>
<p>There is some skepticism that CAR T cells will have the same success in solid tumors. Dr. Rosenberg believes that finding suitable antigens to target on solid tumors&mdash;which has been a major challenge&mdash;may prove to be too difficult in most cases.</p>
<p>&ldquo;Efforts to identify unique antigens on the surface of solid tumors have largely been unsuccessful,&rdquo; he said.</p>
<p>Researchers estimate that the overwhelming majority of tumor antigens reside inside tumor cells, out of the reach of CARs, which can only bind to antigens on the cell surface.</p>
<p>As a result, as has <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131487/">already been shown in melanoma</a>, Dr. Rosenberg said that he believes other forms of ACT may be better suited for solid tumors.</p>
<p>But that doesn&rsquo;t mean that researchers aren&rsquo;t trying with CAR T cells.</p>
<p>For example, investigators are <a href="/clinicaltrials/NCT01583686">conducting trials</a> of CAR T cells that target the protein mesothelin, which is overexpressed on tumor cells in some of the most deadly cancers, including pancreatic and lung cancers, <a href="https://www.ncbi.nlm.nih.gov/pubmed/28724573">and the protein EGFRvIII</a>, which is present on nearly all tumor cells in patients with the aggressive brain cancer glioblastoma.</p>
<p>Early reports from these trials, however, have not reported the same success that&rsquo;s been seen with blood cancers.</p>
<p>&ldquo;As far as targeting antigens on solid tumors the same way we go after CD19, I don&rsquo;t think that&rsquo;s going to work in most cases,&rdquo; Dr. Brentjens acknowledged.</p>
<p>Another key obstacle with solid tumors, he explained, is that components of the microenvironment that surrounds them conspire to blunt the immune response.</p>
<p>So success against solid tumors may require a &ldquo;super T cell,&rdquo; he said, that has been engineered to overcome the immune-suppressing environment of many advanced solid tumors. Work on a CAR T cell with these properties&mdash;<a href="https://www.ncbi.nlm.nih.gov/pubmed/27068948">an &ldquo;armored&rdquo; CAR T cell</a>&mdash;is ongoing at Memorial Sloan Kettering, he said.</p>
<div class="callout-box">
<p><strong>ACT: TILs, TCRs, and CARs</strong></p>
<p>CAR T cells have garnered the lion&rsquo;s share of the attention when it comes to the cellular therapies that fall under the ACT umbrella. But other forms of ACT have also shown promise in small clinical trials, including in patients with solid tumors.</p>
<p>One approach uses immune cells that have penetrated the environment in and around the tumor, known as tumor-infiltrating lymphocytes (TILs). Researchers at NCI were the first to use TILs to successfully treat patients with advanced cancer&mdash;initially <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131487/">in melanoma</a> and later in several other cancers, <a href="/news-events/cancer-currents-blog/2015/immunotherapy-cervical" title="">including cervical cancer</a>. More recently, NCI researchers have developed a technique for identifying TILs that recognize cancer cells with mutations specific to that cancer. In several cases, this approach has led to tumor regressions <a href="http://www.nejm.org/doi/full/10.1056/NEJMoa1609279">in patients with advanced colorectal</a> and liver cancer.</p>
<p>The other primary approach to ACT involves engineering patients&rsquo; T cells to express a specific T-cell receptor (TCR). CARs use portions of synthetic antibodies that can recognize specific antigens only on the surface of cells. TCRs, on the other hand, use naturally occurring receptors that can also recognize antigens that are inside tumor cells. Small pieces of these antigens are shuttled to the cell surface and &ldquo;presented&rdquo; to the immune system as part of a collection of proteins called the MHC complex.</p>
<p>To date, TCR T cells have been tested in patients with a variety of solid tumors, <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361810/">showing promise in melanoma and sarcoma</a>.</p>
</div>
</section>
<section id="evolution">
<h2>Evolution of CAR T-Cell Therapies</h2>
<p>Other refinements or reconfigurations of CAR T cells are being tested. One approach is the development of CAR T-cell therapies that use immune cells collected not from patients, but from healthy donors. The idea is to create so-called off-the-shelf CAR T-cell therapies that are immediately available for use and don&rsquo;t have to be manufactured for each patient.</p>
<p>The French company Cellectis, in fact, has launched a phase I trial of its off-the-shelf CD19-targeted CAR T-cell product in the United States for patients with advanced acute myeloid leukemia. The company&rsquo;s product&mdash;which is made using a gene-editing technology known as TALEN&mdash;has already been tested in Europe, including in two infants with ALL who had exhausted all other treatment options. In both cases, the <a href="https://www.ncbi.nlm.nih.gov/pubmed/28123068">treatment was effective</a>.</p>
<p>Numerous other approaches are under investigation. Researchers, for example, are using nanotechnology to <a href="/news-events/cancer-currents-blog/2017/nanoparticles-engineer-immune-cells" title="">create CAR T cells inside the body</a>, developing CAR T cells with &ldquo;off switches&rdquo; as a means of preventing or limiting side effects like CRS, and using the gene-editing technology&nbsp;<a href="/news-events/cancer-currents-blog/2017/crispr-immunotherapy" title="">CRISPR/Cas9 to more precisely engineer the T cells</a>.</p>
<p>But there is still more to do with existing CAR T-cell therapies, Dr. Fry said.</p>
<p>He is particularly enthusiastic about the potential to use CAR T cells earlier in the treatment process for children with ALL, specifically those who are at high risk (based on specific clinical factors) of their disease returning after their initial chemotherapy, which typically is given for approximately 2 and a half years.</p>
<p>In this scenario, he explained, if early indicators suggested that these high-risk patients weren&rsquo;t having an optimal response to chemotherapy, it could be stopped and the patients could be treated with CAR T cells.</p>
<p>For patients who respond well, &ldquo;they could be spared 2 more years of chemotherapy,&rdquo; Dr. Fry said. &ldquo;That&rsquo;s amazing to think about.&rdquo;</p>
</section>
</div>

	</div>
</div>
							</div>

                            <footer class="article-footer">
                                <div id="cgvCitationSl">
	<div class="contentid-675725 slot-item only-SI">
		
	</div>
</div>
                                <div id="nvcgRelatedResourcesArea">
	<div class="contentid-675725 slot-item only-SI">
		
	</div>
</div>
                                <div id="cgvDate">
	<div class="contentid-675725 slot-item only-SI">
												
				
					
		
	    
        	
				
                			<div class="document-dates horizontal">
			<ul class="clearfix">
									    	    		<li><strong>Updated:</strong> December
 14, 2017</li>    	    
							</ul>
		</div>
	
	</div>
</div>
                                
                                <div id="nvcgSlPublicUse">
	<div class="contentid-911758 slot-item only-SI">
		<div class="public-use">
	<p id="public-use"><i>If you would like to reproduce some or all of this content, see <a href="/policies/copyright-reuse">Reuse of NCI Information</a> for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers was originally published by the National Cancer Institute.”</i></p>

<p id="comment-policy" class="blog-comment-policy">We welcome your comments on this post. All comments must follow our <a href="/policies/comments">comment policy</a>.</p></div>

	</div>
</div>
                                
                                
                            </footer>
                        </article>
                        <!-- ********************************* END Page Content ********************************** -->
                    </div> <!-- END Main -->
                </div> <!-- END "row" -->
            </div> <!-- END "row general-page-body-container collapse" -->
		</div> <!-- End MAIN CONTENT AREA -->	

        </div> <!-- END Page -->

        <!-- FOOTER -->
        <footer class="site-footer">
            <div id="nvcgSlFooter">
	<div class="contentid-911586 slot-item only-SI">
		

<div class="site-footer__container">
<div class="site-footer__header">
<h1>National Cancer Institute <span>at the National Institutes of Health</span></h1>
</div>
<div class="site-footer__nav">
<div class="site-footer__icons">
<h2>FOLLOW US</h2>
<ul>
<li><a class="facebook icon" onclick="NCIAnalytics.FooterLink(this, 'Facebook');" href="/social-media#facebook"> <span class="hidden">Facebook</span> </a></li>
<li><a class="twitter icon" onclick="NCIAnalytics.FooterLink(this, 'Twitter');" href="/social-media#twitter"> <span class="hidden">Twitter</span> </a></li>
<li><a class="instagram icon no-exit-notification" onclick="NCIAnalytics.FooterLink(this, 'Instagram');" href="http://instagram.com/nationalcancerinstitute"> <span class="hidden">Instagram</span> </a></li>
<li><a class="youtube icon" onclick="NCIAnalytics.FooterLink(this, 'YouTube');" href="/social-media#youTube"> <span class="hidden">YouTube</span></a></li>
<li><a class="linkedin icon" onclick="NCIAnalytics.FooterLink(this, 'LinkedIn');" href="/social-media#linkedIn"> <span class="hidden">LinkedIn</span> </a></li>
<li><a class="govdelivery icon" onclick="NCIAnalytics.FooterLink(this, 'GovDelivery');" href="https://public.govdelivery.com/accounts/USNIHNCI/subscriber/new "> <span class="hidden">GovDelivery</span> </a></li>
<li><a class="rss icon" onclick="NCIAnalytics.FooterLink(this, 'RSS');" href="/syndication/rss" title=""> <span class="hidden">RSS</span> </a></li>
</ul>
</div>
<div class="site-footer__contact">
<h2>CONTACT INFORMATION</h2>
<ul>
<li><a onclick="NCIAnalytics.FooterLink(this, 'Contact Us');" href="/contact" title="">Contact Us</a></li>
<li><a onclick="NCIAnalytics.FooterLink(this, 'LiveHelp Chat'); window.open('https://livehelp.cancer.gov', 'LiveHelp','scrollbars=yes,resizable=yes,menubar=yes,toolbar=yes,location=yes,width=650,height=600'); return false;" href="https://livehelp.cancer.gov">LiveHelp Online Chat</a></li>
</ul>
</div>
<div class="site-footer__info">
<h2>MORE INFORMATION</h2>
<ul>
<li><a onclick="NCIAnalytics.FooterLink(this, 'About Website');" href="/about-website" title="">About This Website</a></li>
<li><a onclick="NCIAnalytics.FooterLink(this, 'Cancer.gov en Espanol');" href="/espanol" title="">Cancer.gov en espa&ntilde;ol</a></li>
<li><a onclick="NCIAnalytics.FooterLink(this, 'Multimedia');" href="/multimedia" title="">Multimedia</a></li>
<li><a onclick="NCIAnalytics.FooterLink(this, 'Publications');" href="/publications" title="">Publications</a></li>
<li><a onclick="NCIAnalytics.FooterLink(this, 'Site Map');" href="/about-website/sitemap" title="">Site Map</a></li>
<li><a onclick="NCIAnalytics.FooterLink(this, 'Digital Standards');" href="/digital-standards" title="">Digital Standards for NCI Websites</a></li>
</ul>
</div>
<div class="site-footer__policies">
<h2>POLICIES</h2>
<ul>
<li><a onclick="NCIAnalytics.FooterLink(this, 'Accessibility');" href="/policies/accessibility" title="">Accessibility</a></li>
<li><a onclick="NCIAnalytics.FooterLink(this, 'Comments');" href="/policies/comments" title="">Comment Policy</a></li>
<li><a onclick="NCIAnalytics.FooterLink(this, 'Disclaimer');" href="/policies/disclaimer" title="">Disclaimer</a></li>
<li><a onclick="NCIAnalytics.FooterLink(this, 'FOIA');" href="/policies/foia" title="">FOIA</a></li>
<li><a onclick="NCIAnalytics.FooterLink(this, 'Privacy and Security');" href="/policies/privacy-security" title="">Privacy &amp; Security</a></li>
<li><a onclick="NCIAnalytics.FooterLink(this, 'Reuse');" href="/policies/copyright-reuse" title="">Reuse &amp; Copyright</a></li>
<li><a onclick="NCIAnalytics.FooterLink(this, 'Syndication');" href="/syndication" title="">Syndication Services</a></li>
<li><a onclick="NCIAnalytics.FooterLink(this, 'Linking');" href="/policies/linking" title="">Website Linking</a></li>
</ul>
</div>
</div>
<div class="site-footer__agencies">
<ul>
<li><a onclick="NCIAnalytics.FooterLink(this, 'HHS');" href="http://www.hhs.gov/">U.S. Department of Health and Human Services</a></li>
<li><a onclick="NCIAnalytics.FooterLink(this, 'NIH');" href="http://www.nih.gov">National Institutes of Health</a></li>
<li><a onclick="NCIAnalytics.FooterLink(this, 'NCI');" href="/">National Cancer Institute</a></li>
<li><a onclick="NCIAnalytics.FooterLink(this, 'USA.gov');" href="http://usa.gov">USA.gov</a></li>
</ul>
</div>
<div class="site-footer__tagline">
<h4>NIH ... Turning Discovery Into Health <sup>&reg;</sup></h4>
</div>
<a class="back-to-top" href="#top">TOP</a></div>

	</div>
</div>
        </footer>
        <!-- END FOOTER -->
        
        <!-- UNIVERSAL ANALYTICS AND DTM PAGEBOTTOM TAGS - DO NOT MODIFY -->
        <script id="_fed_an_ua_tag" src="https://dap.digitalgov.gov/Universal-Federated-Analytics-Min.js?agency=HHS&subagency=NCI" defer></script>
        <script type="text/javascript">_satellite.pageBottom();</script>
    </body>

</html>